DanCann Pharma AS (STU:DAN0) Pretax Margin %: -96.31% (As of Sep. 2025)

What is DanCann Pharma AS Pretax Margin %?

DanCann Pharma AS STU:DAN0 27 Pretax Margin % is -96.31% as of Sep. 2025. GuruFocus rates STU:DAN0 with a GF Score™ of 27/100. The stock has 3 warning signs investors should review.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. DanCann Pharma AS's Pre-Tax Income for the three months ended in Sep. 2025 was €-0.21 Mil. DanCann Pharma AS's Revenue for the three months ended in Sep. 2025 was €0.22 Mil. Therefore, DanCann Pharma AS's pretax margin for the quarter that ended in Sep. 2025 was -96.31%.

The historical rank and industry rank for DanCann Pharma AS's Pretax Margin % or its related term are showing as below:

STU:DAN0' s Pretax Margin % Range Over the Past 10 Years
Min: -1737.41 Med: -648.64 Max: -112.56
Current: -214.25

STU:DAN0's Pretax Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 7.285 vs STU:DAN0: -214.25

DanCann Pharma AS (STU:DAN0) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

DanCann Pharma AS Pretax Margin % Related Terms

DanCann Pharma AS Pretax Margin % Historical Data

* Premium members only.

The historical data trend for DanCann Pharma AS's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DanCann Pharma AS Pretax Margin % Chart

DanCann Pharma AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Pretax Margin %

Get a 7-Day Free Trial

0.00

-1,730.51

-317.34

-980.05

-112.58

DanCann Pharma AS Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25
Pretax Margin %	Get a 7-Day Free Trial															-94.38	-159.67	-1,190.91	-234.81	-96.31

STU:DAN0 vs ZTS, UTHR, RGC: Pretax Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, DanCann Pharma AS's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DanCann Pharma AS Pretax Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DanCann Pharma AS's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where DanCann Pharma AS's Pretax Margin % falls into.

Save Embed

27GF Score

DanCann Pharma AS STU:DAN0

Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

DanCann Pharma AS Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

DanCann Pharma AS's Pretax Margin for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-1.119	/	0.994
	=	-112.58 %

DanCann Pharma AS's Pretax Margin for the quarter that ended in Sep. 2025 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Sep. 2025 )	/	Revenue (Q: Sep. 2025 )
	=	-0.209	/	0.217
	=	-96.31 %

Frequently Asked Questions Learn more about Pretax Margin % →

What does a Pretax Margin % of -96.31% mean?

DanCann Pharma AS (STU:DAN0) has a Pretax Margin % of -96.31% as of Sep. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on DanCann Pharma AS and its competitors.

Is DanCann Pharma AS's Pretax Margin % too high?

DanCann Pharma AS's current Pretax Margin % is -96.31%. Overall, DanCann Pharma AS has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.

How does DanCann Pharma AS's Pretax Margin % compare to ZTS and UTHR?

DanCann Pharma AS's Pretax Margin % of -96.31% can be compared against companies in the Drug Manufacturers industry. The industry median Pretax Margin % is 7.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Pretax Margin % for a Drug Manufacturers company?

The median Pretax Margin % among Drug Manufacturers companies is 7.29, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Pretax Margin % mean?

A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on DanCann Pharma AS and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DanCann Pharma AS's current Pretax Margin % is -96.31%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is DanCann Pharma AS stock overvalued right now?

DanCann Pharma AS (STU:DAN0) has a current Pretax Margin % of -96.31%. The current Pretax Margin % is -96.31%. DanCann Pharma AS's overall GF Score™ is 27/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Pretax Margin % calculated?

Pretax Margin % is calculated from a company's financial statements. For DanCann Pharma AS (STU:DAN0), the current Pretax Margin % is -96.31% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DanCann Pharma AS Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies XTER:MRK SHSE:600276 ZTS TSE:4502 LSE:HLN XSWX:GALD NSE:SUNPHARMA XTAE:TEVA XSWX:SDZ HKSE:03692 UTHR NSE:DIVISLAB TSE:4507 SHSE:688506 RGC VTRS NSE:TORNTPHARM SZSE:000538 NBIX XPAR:IPN

Address Rugvaenget 5, Ansager, DNK, DK-6823

Website https://www.dancann.com

DanCann Pharma AS is a Danish biopharmaceutical Company powered by cannabinoids. DanCann Pharma is a licensed production and distribution Company. The company is focused on discovering, developing, manufacturing, and commercializing novel cannabinoid therapeutics for a broad range of diseases.

27GF Score

Get the complete analysis for STU:DAN0

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.00

Price

View STU:DAN0 Analysis

See Pretax Margin % data for all stocks →